✦ LIBER ✦

Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients

✍ Scribed by A. Matucci; P. Parronchi; A. Vultaggio; O. Rossi; F. Brugnolo; E. Maggi; S. Romagnani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability to new COX-2 inhibitors in

✍ Borges, Mario Sánchez; Capriles-Hulett, Arnaldo; Caballero-Fonseca, Fernan; Pére 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Safety of selective cyclooxygenase-2 inh

✍ Quiralte, Joaquín; de San Pedro, Blanca Sáenz; Florido, J. José Fernando 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Superiority of the gastroduodenal safety

✍ M. MOREAU; S. DAMINET; J. MARTEL-PELLETIER; J. FERNANDES; J.-P. PELLETIER 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

COX-2 inhibitor compared with proton pum

✍ Kam-Chuen Lai; Kent-Man Chu; Wai-Mo Hui; Chun-Yu Wong; Wayne Hu; Wai-Man Yuen; M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Safety of Selective COX‐2 Inhibitors in

✍ Bavbek, Sevim; Çelik, Gülfem; Özer, Faruk; Mungan, Dilşad; Mısırlıgil, Zeynep 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 163 KB

Are drug provocation tests still necessa

✍ Çelik, G.E.; Erkekol, F.Ö.; Aydın, Ö.; Demirel, Y.S.; Mısırlıgil, Z. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 310 KB